TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, has announced the formation of its Scientific Advisory Board (SAB).
Aptamer, the developer of next-generation synthetic binders for the life sciences industry, has announced that it has signed a new therapeutic development agreement with Invizius.
Qureight has announced the appointment of Craig Rhodes as head of partnerships to lead strategic engagements with pharmaceutical organisations, in line with Qureight’s revenue growth targets.
SGD Pharma, a provider of pharmaceutical glass packaging, has announced an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial S.r.l, a producer of Tubular Vials and Ampoules headquartered in Italy.
Tasso, a company in patient-centric blood collection, and SheMed, a UK-based women’s healthcare company, have teamed up to deliver safer, more personalised weight loss treatments through convenient at-home diagnostics.
Cold Chain Technologies (CCT), has reinforced its commitment to expanding its Asia Pacific (APAC) presence with a series of investments and partnerships.
Scenic Biotech, a pioneer in modifier therapies for severe diseases, has announced a license and research agreement with Alnylam Pharmaceuticals to leverage Scenic's Cell-Seq platform for discovering novel targets for RNAi therapeutics.
Er-Kim, an international pharma company specialising in the commercialisation of novel therapies, has announced a distribution agreement with CNX Therapeutics to supply selected oncology products across Central & Eastern Europe (CEE) and Türkiye.
Asymchem, a company in contract development and manufacturing (CDMO) solutions, has announced an expansion of its flow chemistry capabilities at its Sandwich, UK facility.
Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO), has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford.
